Assignee
CELLADON CORP
US·0 granted patents·6 pending applications·0 citations·filing 2007–2016
Top patents by PatentIndex Score
6 records- 0162US2014107191A1Method for enhanced uptake of viral vectors in the myocardiumCELLADON CORP·Filed 2013·Application pending·0 cites
- 0256US2008076730A1Extended antegrade epicardial coronary infusion of adeno-associated viral vectors for gene therapyCELLADON CORP·Filed 2007·Application pending·0 cites
- 0347US2017252462A1Extended antegrade epicardial coronary infusion of adeno-associated viral vectors for gene therapyCELLADON CORP·Filed 2016·Application pending·0 cites
- 0446US2008312177A1Serca2 therapeutic compositions and methods of useCELLADON CORP·Filed 2008·Application pending·0 cites
- 0545US2018099029A9Serca2 therapeutic compositions and methods of useCELLADON CORP·Filed 2013·Application pending·0 cites
- 0639US2011172144A1Methods for increasing expression of serca2a in cardiac muscleCELLADON CORP·Filed 2011·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →